Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Bree KK"'
Autor:
Lobo N; Cambridge University Hospitals, Cambridge, UK; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Duan Z; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sood A; Ohio State University, Columbus, OH, USA., Zhao H; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lindskrog SV; Aarhus University, Aarhus, Denmark., Dyrskjot L; Aarhus University, Aarhus, Denmark., Giordano SH; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Williams SB; University of Texas Medical Branch, Galveston, TX, USA., Bree KK; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kamat AM; University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: akamat@mdanderson.org.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2024 Oct 23. Date of Electronic Publication: 2024 Oct 23.
Autor:
Myers AA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tan WS; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Grajales V; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hwang H; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bree KK; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Navai N; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee BH; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dinney CPN; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kamat AM; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: akamat@mdanderson.org.
Publikováno v:
European urology [Eur Urol] 2024 Oct; Vol. 86 (4), pp. 366-368. Date of Electronic Publication: 2024 Jun 14.
Autor:
Lobo N; Department of Urology, Royal Free London NHS Trust, London, UK; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Duan Z; Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sood A; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tan WS; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Grajales V; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Contieri R; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lindskrog SV; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Dyrskjøt L; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Zhao H; Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Giordano SH; Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Williams SB; Department of Urology, University of Texas Medical Branch, Galveston, TX, USA., Bree KK; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kamat AM; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: akamat@mdanderson.org.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2024 Oct; Vol. 7 (5), pp. 1069-1079. Date of Electronic Publication: 2024 Feb 01.
Autor:
Bree KK; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Janes JL; Division of Urology, Durham Veterans Affairs Health Care System, Durham, NC, USA., Hensley PJ; Department of Urology, University of Kentucky College of Medicine, Lexington, KY, USA., Srinivasan A; Division of Urology, Department of Surgery, University of Texas Medical Branch, Galveston, TX, USA., De Hoedt AM; Division of Urology, Durham Veterans Affairs Health Care System, Durham, NC, USA., Das S; Division of Urology, Durham Veterans Affairs Health Care System, Durham, NC, USA.; Department of Urology, University of California-Los Angeles, Los Angeles, CA, USA.; Department of Urology, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Freedland SJ; Division of Urology, Durham Veterans Affairs Health Care System, Durham, NC, USA.; Department of Urology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Center for Integrated Research on Cancer and Lifestyle, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Williams SB; Division of Urology, Department of Surgery, University of Texas Medical Branch, Galveston, TX, USA.
Publikováno v:
BJU international [BJU Int] 2024 Sep; Vol. 134 (3), pp. 473-483. Date of Electronic Publication: 2024 Apr 29.
Autor:
Li R; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Hensley PJ; Department of Urology, University of Kentucky College of Medicine, Lexington, KY, USA., Gupta S; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Al-Ahmadie H; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Babjuk M; Department of Urology, Second Faculty of Medicine of Charles University, University Hospital Motol, Prague, Czechia., Black PC; Department of Urologic Sciences, University of British Columbia, Vancouver, Canada., Brausi M; Department of Urology, Hesperia Hospital, Modena, Italy., Bree KK; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fernández MI; Department of Urology, Clinica Alemana Universidad del Desarrollo, Santiago, Chile., Guo CC; Department of Genitourinary Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Horowitz A; Departments of Immunology & Immunotherapy and Oncological Sciences, Lipschultz Precision Immunology Institute and The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Lamm DL; BCG Oncology PC, University of Arizona College of Medicine, Phoenix, AZ. USA., Lerner SP; Scott Department of Urology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA., Lotan Y; Department of Urology, UT Southwestern Medical Center, Dallas, TV, USA., Mariappan P; Edinburgh Bladder Cancer Surgery, University of Edinburgh, Department of Urology, Western General Hospital, Edinburgh, UK., McConkey D; Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA., Mertens LS; Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Mir C; Department of Urology, Hospital Universitario La Ribera, Valencia, Spain., Ross JS; Upstate Medical University, Syracuse, NY, USA; Foundation Medicine, Boston, MA USA., O'Donnell M; Carver College of Medicine, University of Iowa, Iowa City, IA, USA., Palou J; Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., Pohar K; Department of Urology, Ohio State University, Columbus, OH, USA., Steinberg G; Department of Urology, Rush University Medical Center, Chicago, IL, USA., Soloway M; Memorial Hospital, Hollywood, FL, USA., Spiess PE; Moffitt Cancer Center, Morsani College of Medicine, University of South Florida Tampa, FL, USA., Svatek RS; Department of Urology, University of Texas Health San Antonio, San Antonio, TX, USA., Tan WS; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Taoka R; Faculty of Medicine, Kagawa University, Kagawa, Japan., Buckley R; North York General Hospital, Toronto, Canada., Kamat AM; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: akamat@mdanderson.org.
Publikováno v:
European urology [Eur Urol] 2024 Aug 24. Date of Electronic Publication: 2024 Aug 24.
Autor:
Sood A; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Urology, The James Cancer Hospital and Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus, Ohio., Rudzinski JK; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Labbate CV; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hensley PJ; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Bree KK; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Guo CC; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Alhalabi O; Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Campbell MT; Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Siefker-Radtke AO; Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Navai N; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Dinney CPN; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gao J; Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kamat AM; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
The Journal of urology [J Urol] 2024 Feb; Vol. 211 (2), pp. 241-255. Date of Electronic Publication: 2023 Nov 03.
Autor:
Bree KK; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas., Kokorovic A; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Urology, Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada., Westerman ME; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Urology, Louisiana State University Health Science Center-New Orleans, New Orleans, Louisiana., Hensley PJ; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Urology, University of Kentucky, Lexington, Kentucky., Brooks NA; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Urology, University of Pittsburgh Medical Center Central Pennsylvania, Harrisburg, Pennsylvania., Qiao W; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas., Shen Y; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas., Kamat AM; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas., Dinney CP; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas., Navai N; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
The Journal of urology [J Urol] 2023 Aug; Vol. 210 (2), pp. 254-255. Date of Electronic Publication: 2023 May 22.
Autor:
Faulk A; School of Medicine, LSU Health Science Center-New Orleans, New Orleans, LA, USA., Avulova S; Department of Urology, Albany Medical Center, Albany, NY, USA., Bree KK; Department of Urology, MD Anderson Cancer Center, Houston, TX, USA., Baak-Kukreja J; Division of Urology, University of Colorado, Aurora, CO, USA., Westerman ME; Department of Urology, LSU Health Science Center-New Orleans, New Orleans, LA, USA; Department of Surgery, East Jefferson General Hospital, Metairie, LA, USA. Electronic address: mweste@lsuhsc.edu.
Publikováno v:
European urology focus [Eur Urol Focus] 2023 Jul; Vol. 9 (4), pp. 571-574. Date of Electronic Publication: 2023 May 02.
Autor:
Wang XS; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Bree KK; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Navai N; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Kamal M; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Shen SE; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Letona E; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Cleeland CS; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Shi Q; School of Public Health and Management, Chongqing Medical University, Chongqing 400016, China., Gottumukkala V; Department of Anesthesiology & Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Jun 04; Vol. 15 (11). Date of Electronic Publication: 2023 Jun 04.